Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 0.27 is 252% above its 3-year average of 0.08, around the middle of its 3-year range (-0.04–0.68).
As of the fiscal period ended Tuesday, March 31, 2026. 83.67% above its 12-month average of 0.15.
Reported quarterly quick ratio; no daily interpolation. Q4 FY2025 (2026-03-31): 0.27.
QUICK RATIO (ACID-TEST)
0.27
QUICK RATIO (ACID-TEST) AVG TTM
0.15
QUICK RATIO (ACID-TEST) AVG 3Y
0.01
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+83.67%
CURRENT VS 3Y AVG
+1808.79%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.15
median of 685 covered companies
CURRENT VS SECTOR MEDIAN
-91.41%
vs the sector median at left
Market Cap
$63.30M
Quick Ratio (Acid-Test)
10.98
TTM Avg
17.43
3Y Avg
9.10
5Y Avg
12.08
Market Cap
$63.14M
Quick Ratio (Acid-Test)
0.97
TTM Avg
1.07
3Y Avg
1.19
5Y Avg
1.33
Market Cap
$63.78M
Quick Ratio (Acid-Test)
9.90
TTM Avg
11.46
3Y Avg
13.71
5Y Avg
15.39
Market Cap
$63.79M
Quick Ratio (Acid-Test)
1.51
TTM Avg
1.60
3Y Avg
1.72
5Y Avg
2.07
Market Cap
$61.23M
Quick Ratio (Acid-Test)
6.71
TTM Avg
8.38
3Y Avg
9.61
5Y Avg
10.03
Market Cap
$66.02M
Quick Ratio (Acid-Test)
3.50
TTM Avg
1.85
3Y Avg
1.22
5Y Avg
3.58
Market Cap
$60.32M
Quick Ratio (Acid-Test)
2.37
TTM Avg
7.60
3Y Avg
7.51
5Y Avg
12.19
Market Cap
$60.12M
Quick Ratio (Acid-Test)
1.35
TTM Avg
1.97
3Y Avg
5.50
5Y Avg
8.52
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alps Group Inc (ALPS) | $63.23M | 0.27 | 0.15 | 0.01 | N/A |
| Kalaris Therapeutics Inc (KLRS)vs › | $63.30M | 10.98 | 17.43 | 9.10 | 12.08 |
| InterCure Ltd. (INCR)vs › | $63.14M | 0.97 | 1.07 | 1.19 | 1.33 |
| Pliant Therapeutics, Inc. (PLRX)vs › | $63.78M | 9.90 | 11.46 | 13.71 | 15.39 |
| Heron Therapeutics, Inc. (HRTX)vs › | $63.79M | 1.51 | 1.60 | 1.72 | 2.07 |
| Adicet Bio, Inc. (ACET)vs › | $61.23M | 6.71 | 8.38 | 9.61 | 10.03 |
| Cingulate Inc. (CING)vs › | $66.02M | 3.50 | 1.85 | 1.22 | 3.58 |
| Connect Biopharma Holdings Limited (CNTB)vs › | $60.32M | 2.37 | 7.60 | 7.51 | 12.19 |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.12M | 1.35 | 1.97 | 5.50 | 8.52 |
| PDS Biotechnology Corporation (PDSB)vs › | $60.24M | 0.57 | 2.81 | 4.44 | 7.47 |
Quick Ratio
0.27
Excludes inventory
Current Ratio
0.36
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-03-31 | 0.27 |
| 2026-03-31 | 0.27 |
| 2025-09-30 | 0.04 |
| 2025-09-30 | 0.04 |
| 2025-06-30 | 0.25 |
| 2025-03-31 | 0.01 |
| 2024-12-31 | -0.03 |
| 2024-09-30 | 0.02 |
| 2024-06-30 | 0.05 |
| 2024-03-31 | 0.03 |
| 2023-12-31 | -0.04 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | 0.68 |
